Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and effects of pneumocandin B0 analog L-733,560.

A new class of promising antipneumocystis agents, cyclic lipopeptide pneumocandin analogs, has been shown to effectively prevent Pneumocystis carinii cyst development in murine models. These compounds are believed to inhibit the biosynthesis of beta-1,3-glucan, a major constituent of the cell walls...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Nollstadt, K H, Powles, M A, Fujioka, H, Aikawa, M, Schmatz, D M
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1994
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284727/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7840554/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.10.2258
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!